Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Some Teenagers Recreated Martin Shkreli's Crazy-Expensive Drug For $20

Huffington Post Thursday, 1 December 2016
When Martin Shkreli, the former CEO of Turing Pharmaceuticals, hiked up the price of a life-saving medication, one group of high school students saw an opportunity to do good.

Eight teenagers from Sydney Grammar School in Australia have collaborated with scientists from the University of Sydney to reproduce the active...
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Newsy Studio - < > Embed

News video: Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose

Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose 01:16

A group of Australian students say they recreated the active ingredient in life-saving drug Daraprim for a fraction of its U.S. price.

You Might Like


Other recent news in Politics

Jacinda Ardern confirms new government will dump TAX CUTSBREXIT: EU leaders agree internal talks on trade with UK
PAUL RYAN Hilariously Roasted Donald Trump During The Al Smith DinnerWhite House holds briefing after SENATE PASSES budget plan -- live blog
TRUMP TAX CUTS gain momentum as Rand Paul goes 'all in'Obama blasts 'politics of division' on return to CAMPAIGN TRAIL
CIA Backs Off Director's Claim That RUSSIAN MEDDLING Didn't Swing ElectionAllegations Of SEXUAL HARASSMENT Against Movie Mogul Spark Global Conversation
MELANIA TRUMP cuts bloated first lady payroll from Michelle Obama daysHILLARY CLINTON Unbowed

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+